Stock LLM Wiki

報告_MS_台積電2330_20260716

更新 2026-07-17

PDF 原檔:報告_MS_台積電2330_20260716_original.pdf

圖片清單(已驗證 2026-07-17)

檔名 size 分類 親眼所見內容
報告_MS_台積電2330_20260716_002.png 75KB 真資料圖 股價/目標價沿革折線圖(2023/07–2026/07),紅色虛線標示歷次 TP 調整節點,由 710/718 一路上調至 2588/2888
報告_MS_台積電2330_20260716_001.png 65KB 裝飾·banner 「Asia Summer School 2026」活動宣傳橫幅(藍色泳池背景+信封圖示)

原始內容

M July 16, 2026 10:14 AM GMT

TSMC | Asia Pacific

2026 revenue and capex guidance raised again; OW

Reaction to earnings

Strengthens our thesis

Impact to our thesis

Source: Company data, Morgan Stanley Research

Key Takeaways

  • TSMC's 2Q26 results and 3Q26 guidance fall in our Catalyst preview Scenarios 1 and 2, where we assume the stock moves up 1-5% in the coming trading days.
  • Mgmt guided 3Q26 revenue to rise 12% Q/Q, in line with MSe 10%-15% Q/Q.
  • 2Q26 gross margin reached 67.7% vs. MSe 67.4%.
  • Foundry competition - mgmt reiterated there are no shortcuts. Leading-edge foundry capabilities take years to develop, and a new fab takes 2-3 years to build.

Other key takeaways:

  • Key positive - 2026 full-year revenue growth guidance raised to above 40% Y/Y (vs. previously above 30% Y/Y): In our 6/28 preview note, we expected guidance to increase to 40% Y/Y, but it came in even above our Street-high forecast, driven by very strong AI demand. Consensus expected an increase to 35%-40% Y/Y.
  • Key negative - GM matched our conservative forecast but missed the Street's elevated margin expectations: With 2nm dilution, 3Q26 guidance at the midpoint is 66% vs. MSe 67.5%, below an unrealistic buyside bogey of 70%. We believe investors should buy on dips following the Street's margin forecast miss.
  • AI demand: CSP customers are rapidly increasing cloud capex. TSMC did not update its projected AI semiconductor revenue CAGR but indicated it is tracking above its previous forecast.
  • 2026 capex raised: TSMC increased its 2026 capex target to US$60-64bn (vs. the previous high end of US$52-US$56bn), implying some equipment cost inflation. As expected, it did not provide the 3-year capex guidance of US$200bn that we had anticipated, but indicated that capex intensity should increase further.
  • Intel EMIB-T used by customers: TSMC welcomed Intel's role in helping alleviate advanced packaging supply constraints and expressed support for customers' success. Notably, MediaTek is a major user of Intel's EMIB-T for a TPU project.

Modest upside

Financial results versus consensus

  • Modest revision higher Direction of next 12-month consensus EPS

Update

Morgan Stanley Taiwan Limited+ Charlie Chan Equity Analyst Charlie.Chan@morganstanley.com +886 2 2730-1725
Daniel Yen, CFA Equity Analyst Daniel.Yen@morganstanley.com +886 2 2730-2863
Daisy Dai, CFA Equity Analyst Daisy.Dai@morganstanley.com +852 2848-7310
Tiffany Yeh Equity Analyst Tiffany.Yeh@morganstanley.com +886 2 7712-3032
Lucas Wang Research Associate Lucas.Wang@morganstanley.com Morgan Stanley Asia Limited+ +886 2 2730-2875
Ethan Jia Research Associate Ethan.Jia@morganstanley.com +852 3963-2287
Henry Zhao Research Associate Henry.Zhao@morganstanley.com +852 2239-7731
報告_MS_台積電2330_20260716_001

TSMC (2330.TW, 2330 TT)

Greater China Technology Semiconductors | Taiwan

Stock Rating Overweight Overweight
Industry View Attractive
Price target Price target Price target NT$2,888.00 NT$2,888.00
Up/downside to price target (%) Up/downside to price target (%) Up/downside to price target (%) 17 17
Shr price, close (Jul 16, 2026) Shr price, close (Jul 16, 2026) Shr price, close (Jul 16, 2026) NT$2,470.00 NT$2,470.00
Mkt cap, curr (mn) Mkt cap, curr (mn) Mkt cap, curr (mn) NT$64,042,111 NT$64,042,111
Avg daily trading value (mn) Avg daily trading value (mn) Avg daily trading value (mn) NT$65,119 NT$65,119
Fiscal Year Ending 12/25 12/26e 12/27e 12/28e
EPS (NT$)** 66.25 107.56 143.01 177.30
Prior EPS (NT$)** - - - -
EPS (NT$)§ 64.56 100.23 130.32 165.91
ModelWare net inc (NT 1,718 2,778 3,708 4,597
$ bn)
P/E 23.4 23.1 17.3 13.9
Div yld (%) 1.4 1.1 1.4 1.7

Morgan Stanley does and seeks to do business with companies covered in Morgan Stanley Research. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of Morgan Stanley Research. Investors should consider Morgan Stanley Research as only a single factor in making their investment decision.